Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitroglycerin and nitrate esters

S E Warren, G S Francis

    The American Journal of Medicine
    |July 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Nitroglycerin and nitrate esters are increasingly vital for treating congestive heart failure, reducing heart attack damage, and preventing angina. This review highlights recent research and offers guidance on their clinical application.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The high-risk patient with heart failure with reduced ejection fraction: treatment options and challenges.

    Clinical pharmacology and therapeutics·2013
    Same author

    Cardiac troponins and chronic kidney disease.

    Kidney international·2006
    Same author

    Plasma BNP concentration predicted the presence of heart failure.

    Evidence-based cardiovascular medicine·2005
    Same author

    Brain natriuretic peptide concentration was effective for screening for LV systolic dysfunction.

    Evidence-based cardiovascular medicine·2005
    Same author

    Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.

    Neurology·2005
    Same author

    Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS study.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2005
    Same journal

    GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

    The American journal of medicine·2026
    Same journal

    Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

    The American journal of medicine·2026
    Same journal

    Cave Canem - Beware of the Dog.

    The American journal of medicine·2026
    Same journal

    Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

    The American journal of medicine·2026
    Same journal

    Mesenteric Panniculitis.

    The American journal of medicine·2026
    Same journal

    Hypercalcemia and hyperferritinemia in a patient with Graves' disease disease.

    The American journal of medicine·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiology
    • Clinical Medicine

    Background:

    • Nitroglycerin and nitrate esters have demonstrated expanding clinical applications.
    • Their importance is growing in managing congestive heart failure, myocardial infarction, and angina prophylaxis.

    Purpose of the Study:

    • To review significant recent investigations of nitroglycerin and nitrate esters.
    • To provide specific recommendations for the clinical use of these drugs.

    Main Methods:

    • Literature review of recent studies on nitrates.
    • Analysis of clinical trial data and pharmacological research.

    Main Results:

    • The review synthesizes findings on the efficacy and safety of nitrates in various cardiovascular conditions.

    Related Experiment Videos

  • Recent investigations underscore the therapeutic benefits and evolving applications of these agents.

    • Conclusions:

    • Nitroglycerin and nitrate esters are essential therapeutic agents in modern cardiovascular medicine.
    • Evidence supports their continued use and guides optimal clinical application for improved patient outcomes.